We are live on ! Find out more
WINT

Windtree Therapeutics Inc
WINT

Delisted

WINT was delisted on the 4th of May, 2017.

Back to rankings

67 hedge funds and large institutions have $93.5M invested in Windtree Therapeutics Inc in 2014 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 20 increasing their positions, 13 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

79% more call options, than puts

Call options by funds: $828K | Put options by funds: $462K

54% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 13

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

8% less funds holding

Funds holding: 73 → 67 (-6)

20% less capital invested

Capital invested by funds: $117M → $93.5M (-$23.1M)

40% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 15

Holders
67
Holders Change
-6
Holders Change %
-8.22%
% of All Funds
1.92%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
9
Increased
20
Reduced
13
Closed
15
Calls
$828K
Puts
$462K
Net Calls
+$366K
Net Calls Change
+$113K

Top Buyers

Rank Fund Capital Flow
1
TCM
Tamarack Capital Management
California
+$913K
2
Millennium Management
Millennium Management
New York
+$573K
3
PRCM
Pine River Capital Management
Minnesota
+$365K
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$269K
5
BIT
BlackRock Institutional Trust
California
+$259K

Top Sellers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
-$2.12M
2
GC
Guggenheim Capital
Illinois
-$700K
3
Morgan Stanley
Morgan Stanley
New York
-$585K
4
TI
Turner Investments
Pennsylvania
-$510K
5
TC
TFS Capital
Pennsylvania
-$458K
Name Holding Trade Value Shares
Change 		Change in
Stake
Marshall Wace
26
Marshall Wace
United Kingdom
$229K +$235K +9,180 New
Group One Trading
27
Group One Trading
Illinois
$212K +$8.92K +349 +4%
Jane Street
28
Jane Street
New York
$162K -$46.1K -1,803 -22%
TC
29
TFS Capital
Pennsylvania
$154K -$458K -17,900 -74%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$117K +$511 +20 +0.4%
State Street
31
State Street
Massachusetts
$102K – – –
FSA
32
Franklin Street Advisors
North Carolina
$83K – – –
BAM
33
Brave Asset Management
New Jersey
$77K +$6.11K +239 +8%
PRCM
34
Pine River Capital Management
Minnesota
$77K +$365K +14,286 New
Commonwealth Equity Services
35
Commonwealth Equity Services
Massachusetts
$72K – – –
GC
36
Guggenheim Capital
Illinois
$69K -$700K -27,401 -91%
CS
37
Credit Suisse
Switzerland
$57K -$204K -7,987 -78%
RCM
38
Rotella Capital Management
Washington
$56K +$57.6K +2,253 New
Dimensional Fund Advisors
39
Dimensional Fund Advisors
Texas
$47K – – –
WSCM
40
Wellington Shields Capital Management
New York
$44K – – –
BA
41
BlackRock Advisors
Delaware
$40K – – –
T. Rowe Price Associates
42
T. Rowe Price Associates
Maryland
$39K – – –
ST
43
Spot Trading
Illinois
$39K +$40.4K +1,580 New
RFC
44
Regions Financial Corp
Alabama
$36K – – –
Stifel Financial
45
Stifel Financial
Missouri
$34K +$13.5K +528 +64%
Morgan Stanley
46
Morgan Stanley
New York
$29K -$585K -22,870 -95%
BL
47
BCWM LLC
Kansas
$29K +$29.2K +1,143 New
BIM
48
BlackRock Investment Management
Delaware
$25K +$25.3K +989 New
PAG
49
Pinnacle Advisory Group
Maryland
$23K +$3.71K +145 +18%
WS
50
Wedbush Securities
California
$22K +$22.3K +874 New
1
2
3 4

WINT Hedge Fund Activity: Q2 2014 in Review

67 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in Windtree Therapeutics Inc (WINT) for Q2 2014, worth a combined $93.5M — down 20% from $117M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of WINT and 9 opened new positions — a net loss of 6 holders — while 13 trimmed existing stakes and 20 added.

The largest buyer was Tamarack Capital Management, adding an estimated $913K. The largest seller was Wells Fargo, cutting an estimated $2.12M.

  • 67 institutional investors held Windtree Therapeutics Inc (WINT) as of Q2 2014, down from 73 in Q1 2014.
  • Funds reported $93.5M of Windtree Therapeutics Inc stock for Q2 2014, down 20% quarter-over-quarter.
  • 9 funds opened new Windtree Therapeutics Inc positions in Q2 2014 and 15 closed out, a net change of -6 holders.
  • The largest Windtree Therapeutics Inc buyer in Q2 2014 was Tamarack Capital Management, an estimated $913K added.
  • The largest Windtree Therapeutics Inc seller in Q2 2014 was Wells Fargo, an estimated $2.12M sold.

Based on aggregated 13F filings for Q2 2014.